A Nation in Pain: U.S. Opioid Trends
An Express Scripts report focuses on U.S. opioid trends for treatment of short-term and longer-term pain.
Read MoreImproving Health
The challenges you face in improving the health of your members may seem daunting.
FDA Approved Drugs: January 2020
The Express Scripts Office of Clinical Evaluation and Policy tracks some recent updates to the drug pipeline.
Read MoremyMatrixx Drug Trend Report: Spending on Opioids Declined 15% in 2018
myMatrixx helped workers' compensation plans reduce overall drug spending by 3.8%, including the largest decrease yet in spending on opioids.
Read MoreThe Personal Impact of Opioid Addiction
The opioid crisis is a national emergency. But it’s the personal toll – 90 lives lost every day – that drives our mission to make the use of opioids safer.
Read MoreFDA Approved Drugs: August 2020
The Express Scripts Office of Clinical Evaluation and Policy lists the drugs that were approved by the Food and Drug Administration (FDA) in July 2020. (Estimated Reading Time: ~10 mins.)
Read MoreFDA Approved Drugs: February 2020
The Express Scripts Office of Clinical Evaluation and Policy tracks some recent updates to the drug pipeline.
Read MoreNational Drug Purchasing Coalition and Express Scripts Team Up to Create New Pharmacy Benefit Design
Read MoreExpress Scripts' Innovative Advanced Opioid Management Solution Shifts First-Time Opioid Users to Safer, Short-Term Prescriptions
Read MoreSafe Opioid Use Across the Care Continuum
Safe opioid use relies on public and private sector solutions that connect patients, prescribers and pharmacists.
Read MoreExpress Scripts' myMatrixx Launches myDataSense Analytics Tool
Read MoreFDA Approved Drugs: October 2020
The Express Scripts Office of Clinical Evaluation and Policy tracks some recent updates to the drug pipeline.
Read MoreMeasuring the Impact of Opioid Crisis Management
Recent enhancements to Express Scripts’ Advanced Opioid Management program continue to improve patient safety and address potential gaps in appropriate care at each touchpoint.
Read MoremyMatrixx Delivers 6.1% Decrease in Workers’ Compensation Prescription Drug Spend
Payers with a workers’ compensation program managed by myMatrixx experienced a 6.1 percent decline in total costs. (Estimated reading time: ~3 mins.)
Read MoreAdvanced Opioid Management Program Focuses on Recovery and Abuse Prevention
Our nationally recognized Advanced Opioid Management program gives employers new tools to help prevent abuse and guide workforce members in need through a successful recovery.
Read MoreA Nation in Pain: The Opioid Crisis and Medicaid
Medicaid members are 10 times more likely to suffer from addiction and substance abuse than the general population.
Read More